Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AUNG NAING

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1104837590
CMS profile
366226
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$4,309.43

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $3,944.53 10
Food and Beverage $364.90 6

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Eli Lilly and Company $4,191.76 15
PFIZER INC. $117.67 1

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AUNG NAING

NPI 1104837590 · CMS profile ID 366226

Allopathic & Osteopathic Physicians / Internal Medicine

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104837590?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AUNG NAING, NPI 1104837590, CMS profile ID 366226. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104837590?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). AUNG NAING, NPI 1104837590, CMS profile ID 366226. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104837590?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
AUNG NAING, NPI 1104837590, CMS profile ID 366226, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1104837590?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $4,309.43 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $117.6706/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672262367 CMS
Eli Lilly and Company $590.7605/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657686397 CMS
Eli Lilly and Company $79.9705/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657689841 CMS
Eli Lilly and Company $171.1305/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657689843 CMS
Eli Lilly and Company $14.9805/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657693327 CMS
Eli Lilly and Company $110.3804/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657700187 CMS
Eli Lilly and Company $74.9204/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657682831 CMS
Eli Lilly and Company $343.3304/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657682833 CMS
Eli Lilly and Company $116.8204/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657682835 CMS
Eli Lilly and Company $1,131.2004/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657686395 CMS
Eli Lilly and Company $252.4604/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657689839 CMS
Eli Lilly and Company $45.9404/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657693323 CMS
Eli Lilly and Company $21.9904/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657693325 CMS
Eli Lilly and Company $31.4204/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657696735 CMS
Eli Lilly and Company $1,029.9604/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657700183 CMS
Eli Lilly and Company $176.5004/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657700185 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,309.43 16
PY2020 $211.34 1
PY2021 $2,639.00 1
PY2022 $5,205.00 2
PY2023 $3,375.00 2
PY2025 $4,703.88 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $3,918,481.53 469
PY2024 Recipient $4,531.10 4
PY2024 Principal investigator $4,445,667.71 159
PY2023 Principal investigator $4,761,955.67 97
PY2022 Principal investigator $3,708,621.77 334
PY2021 Principal investigator $5,802,399.26 154
PY2020 Recipient $2,459.66 4
PY2020 Principal investigator $1,927,221.68 148
PY2019 Principal investigator $5,972,979.75 356

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

469 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249662
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249666
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249670
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249674
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249678
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249682
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249686
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249690
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249695
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249699
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249702
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249706
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249710
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249715
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249719
Principal investigator 1 Coherus Oncology, Inc. $375.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250066
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250070
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250074
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250078
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250083
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250086
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250090
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250094
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250099
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250103
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250106
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250110
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250114
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250118
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250121
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250125
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250128
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250131
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250135
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250138
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250142
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250146
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250150
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250154
Principal investigator 1 Coherus Oncology, Inc. $85.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250157
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250161
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250165
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250170
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250174
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250177
Principal investigator 1 Coherus Oncology, Inc. $101.44 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250182
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250186
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250189
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250193
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250198
Principal investigator 1 Coherus Oncology, Inc. $425.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250201
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250205
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250208
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250212
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250216
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250220
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250223
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250228
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250231
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250234
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250238
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250242
Principal investigator 1 Coherus Oncology, Inc. $375.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250245
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250249
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250252
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250255
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250260
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250263
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250266
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250270
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250273
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250278
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250281
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250284
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250287
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250291
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250378
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250382
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250386
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250389
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250392
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250396
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250400
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250404
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250409
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250412
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250416
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250419
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250423
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250428
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250433
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250437
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250576
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250580
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250603
Principal investigator 1 Coherus Oncology, Inc. $773.64 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250606
Principal investigator 1 Coherus Oncology, Inc. $81.76 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250611
Principal investigator 1 Coherus Oncology, Inc. $101.44 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250614
Principal investigator 1 Coherus Oncology, Inc. $79.97 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250618
Principal investigator 1 Coherus Oncology, Inc. $375.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250622
Principal investigator 1 Coherus Oncology, Inc. $163.52 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250627
Principal investigator 1 Coherus Oncology, Inc. $159.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250630
Principal investigator 1 Coherus Oncology, Inc. $85.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250634
Principal investigator 1 Coherus Oncology, Inc. $212.50 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250638
Principal investigator 1 Coherus Oncology, Inc. $425.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250641
Principal investigator 1 Coherus Oncology, Inc. $599.16 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250646
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250653
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250657
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250661
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250665
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250668
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250672
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250676
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250680
Principal investigator 1 Coherus Oncology, Inc. $163.52 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250685
Principal investigator 1 Coherus Oncology, Inc. $101.44 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250689
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250692
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250696
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250699
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250703
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250706
Principal investigator 1 Coherus Oncology, Inc. $101.44 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250710
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250714
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250718
Principal investigator 1 Coherus Oncology, Inc. $212.50 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250722
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250726
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250730
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250733
Principal investigator 1 Coherus Oncology, Inc. $85.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250738
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250742
Principal investigator 1 Coherus Oncology, Inc. $159.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250746
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250750
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250753
Principal investigator 1 Coherus Oncology, Inc. $375.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250757
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250761
Principal investigator 1 Coherus Oncology, Inc. $159.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250765
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250769
Principal investigator 1 Coherus Oncology, Inc. $101.44 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250773
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250777
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250781
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250784
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250788
Principal investigator 1 Coherus Oncology, Inc. $299.58 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250792
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250795
Principal investigator 1 Coherus Oncology, Inc. $159.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250799
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250802
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250806
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250810
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250814
Principal investigator 1 Coherus Oncology, Inc. $85.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250818
Principal investigator 1 Coherus Oncology, Inc. $85.94 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250821
Principal investigator 1 Coherus Oncology, Inc. $1,250.00 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250826
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250830
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250834
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250838
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250842
Principal investigator 1 Coherus Oncology, Inc. $118.75 12/12/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250846
Principal investigator 1 BeOne Medicines USA, Inc. $5,956.00 12/09/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190336107
Principal investigator 1 BeOne Medicines Ltd. $32,784.00 12/01/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190342399
Principal investigator 1 PFIZER INC. $14,744.50 11/14/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
AN OPENLABEL PHASE 1 STUDY TO EVALUATE PF08046032 AS MONOTHERAPY AND PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED MALIGNANCIES No dispute reported 06/30/2026 1228813476
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249247
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249251
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249255
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249259
Principal investigator 1 Coherus Oncology, Inc. $117.23 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249263
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249268
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249272
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249276
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249280
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249321
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249325
Principal investigator 1 Coherus Oncology, Inc. $90.41 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249329
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249334
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249338
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249341
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249346
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249350
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249354
Principal investigator 1 Coherus Oncology, Inc. $297.62 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249358
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249362
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249366
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249371
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249375
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249379
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249383
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249387
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249391
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249396
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249399
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249403
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249407
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249411
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249415
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249420
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249422
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249426
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249430
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249434
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249438
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249442
Principal investigator 1 Coherus Oncology, Inc. $90.41 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249444
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249448
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249452
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249456
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249460
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249465
Principal investigator 1 Coherus Oncology, Inc. $189.99 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249468
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249473
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249476
Principal investigator 1 Coherus Oncology, Inc. $210.94 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249480
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249483
Principal investigator 1 Coherus Oncology, Inc. $117.24 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249486
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249490
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249494
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249500
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249504
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249508
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249511
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249515
Principal investigator 1 Coherus Oncology, Inc. $117.24 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249519
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249522
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249526
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249531
Principal investigator 1 Coherus Oncology, Inc. $735.51 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249534
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249538
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249542
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249546
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249550
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249554
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249558
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249562
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249564
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249567
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249570
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249573
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249578
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249582
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249587
Principal investigator 1 Coherus Oncology, Inc. $212.05 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249590
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249594
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249598
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249602
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249605
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249609
Principal investigator 1 Coherus Oncology, Inc. $212.05 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249612
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249616
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249619
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249623
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249627
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249631
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249634
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249639
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249644
Principal investigator 1 Coherus Oncology, Inc. $189.99 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249648
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249653
Principal investigator 1 Coherus Oncology, Inc. $735.51 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249658
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249722
Principal investigator 1 Coherus Oncology, Inc. $334.79 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249728
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249731
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249735
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249740
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249742
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249748
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249752
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249755
Principal investigator 1 Coherus Oncology, Inc. $191.86 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249759
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249763
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249767
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249771
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249775
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249779
Principal investigator 1 Coherus Oncology, Inc. $164.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249783
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249788
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249793
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249798
Principal investigator 1 Coherus Oncology, Inc. $629.59 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249802
Principal investigator 1 Coherus Oncology, Inc. $471.75 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249806
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249809
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249814
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249818
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249822
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249827
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249831
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249835
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249838
Principal investigator 1 Coherus Oncology, Inc. $334.79 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249843
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249846
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249850
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249854
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249860
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249864
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249868
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249872
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249879
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249882
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249886
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249890
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249894
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249898
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249902
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249906
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249910
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249914
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249918
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249921
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249925
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249929
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249931
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249934
Principal investigator 1 Coherus Oncology, Inc. $514.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249938
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249942
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249946
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249950
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249954
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249958
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249962
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249968
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249972
Principal investigator 1 Coherus Oncology, Inc. $334.79 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249976
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249980
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249984
Principal investigator 1 Coherus Oncology, Inc. $334.79 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249988
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249992
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249996
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235249999
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250004
Principal investigator 1 Coherus Oncology, Inc. $117.23 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250008
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250011
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250014
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250018
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250023
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250026
Principal investigator 1 Coherus Oncology, Inc. $629.59 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250030
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250034
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250038
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250041
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250046
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250050
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250054
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250058
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250062
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250294
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250297
Principal investigator 1 Coherus Oncology, Inc. $117.23 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250301
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250304
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250308
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250312
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250315
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250319
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250322
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250326
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250330
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250333
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250336
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250340
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250344
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250347
Principal investigator 1 Coherus Oncology, Inc. $117.23 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250351
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250356
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250359
Principal investigator 1 Coherus Oncology, Inc. $182.48 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250362
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250366
Principal investigator 1 Coherus Oncology, Inc. $514.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250369
Principal investigator 1 Coherus Oncology, Inc. $437.30 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250374
Principal investigator 1 Coherus Oncology, Inc. $90.41 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250441
Principal investigator 1 Coherus Oncology, Inc. $290.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250445
Principal investigator 1 Coherus Oncology, Inc. $117.24 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250450
Principal investigator 1 Coherus Oncology, Inc. $3,125.00 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250454
Principal investigator 1 Coherus Oncology, Inc. $93.92 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250458
Principal investigator 1 Coherus Oncology, Inc. $437.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250462
Principal investigator 1 Coherus Oncology, Inc. $260.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250465
Principal investigator 1 Coherus Oncology, Inc. $471.74 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250469
Principal investigator 1 Coherus Oncology, Inc. $327.29 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250472
Principal investigator 1 Coherus Oncology, Inc. $212.05 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250476
Principal investigator 1 Coherus Oncology, Inc. $629.59 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250481
Principal investigator 1 Coherus Oncology, Inc. $204.54 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250485
Principal investigator 1 Coherus Oncology, Inc. $191.86 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250489
Principal investigator 1 Coherus Oncology, Inc. $514.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250493
Principal investigator 1 Coherus Oncology, Inc. $297.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250497
Principal investigator 1 Coherus Oncology, Inc. $975.00 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250500
Principal investigator 1 Coherus Oncology, Inc. $297.62 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250505
Principal investigator 1 Coherus Oncology, Inc. $377.16 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250509
Principal investigator 1 Coherus Oncology, Inc. $218.48 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250513
Principal investigator 1 Coherus Oncology, Inc. $117.23 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250517
Principal investigator 1 Coherus Oncology, Inc. $437.30 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250520
Principal investigator 1 Coherus Oncology, Inc. $656.25 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250525
Principal investigator 1 Coherus Oncology, Inc. $471.75 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250528
Principal investigator 1 Coherus Oncology, Inc. $4,687.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250532
Principal investigator 1 Coherus Oncology, Inc. $246.62 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250536
Principal investigator 1 Coherus Oncology, Inc. $182.48 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250540
Principal investigator 1 Coherus Oncology, Inc. $164.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250545
Principal investigator 1 Coherus Oncology, Inc. $334.79 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250549
Principal investigator 1 Coherus Oncology, Inc. $119.11 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250553
Principal investigator 1 Coherus Oncology, Inc. $286.67 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250558
Principal investigator 1 Coherus Oncology, Inc. $297.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250561
Principal investigator 1 Coherus Oncology, Inc. $655.60 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250564
Principal investigator 1 Coherus Oncology, Inc. $604.99 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250568
Principal investigator 1 Coherus Oncology, Inc. $383.46 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250572
Principal investigator 1 Coherus Oncology, Inc. $593.40 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250908
Principal investigator 1 Coherus Oncology, Inc. $253.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250913
Principal investigator 1 Coherus Oncology, Inc. $517.93 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250917
Principal investigator 1 Coherus Oncology, Inc. $735.51 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250922
Principal investigator 1 Coherus Oncology, Inc. $99.17 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250926
Principal investigator 1 Coherus Oncology, Inc. $408.61 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250930
Principal investigator 1 Coherus Oncology, Inc. $182.50 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250933
Principal investigator 1 Coherus Oncology, Inc. $210.94 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250937
Principal investigator 1 Coherus Oncology, Inc. $182.49 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250942
Principal investigator 1 Coherus Oncology, Inc. $189.99 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250945
Principal investigator 1 Coherus Oncology, Inc. $488.73 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250948
Principal investigator 1 Coherus Oncology, Inc. $212.04 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250952
Principal investigator 1 Coherus Oncology, Inc. $189.98 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250956
Principal investigator 1 SANOFI US SERVICES INC. $311,409.26 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127903
Principal investigator 1 SANOFI US SERVICES INC. $224,539.18 11/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127939
Principal investigator 1 BeOne Medicines Ltd. $32,784.00 11/04/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190342403
Principal investigator 1 Servier BioInnovation $413.79 11/03/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
S95029 Alone and in Combination with Sym021 in Patients with Advanced Solid Tumors followed by an Expansion Phase of Triple Combinations No dispute reported 06/30/2026 1235967327
Principal investigator 1 Servier BioInnovation $1,009.06 11/03/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
S95029 Alone and in Combination with Sym021 in Patients with Advanced Solid Tumors followed by an Expansion Phase of Triple Combinations No dispute reported 06/30/2026 1235967329
Principal investigator 1 BeOne Medicines USA, Inc. $5,193.00 10/28/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190336103
Principal investigator 1 Coherus Oncology, Inc. $3,677.47 10/24/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250905
Principal investigator 1 Merck Sharp & Dohme LLC $331,200.00 10/16/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
AN OPEN-LABEL PHASE 1,2A STUDY OF GV20-0251 MONOTHERAPY AND GV20-0251 IN COMBINATION WITH PEMBROLIZUMAB IN PARTICIPANTS WITH ADVANCED AND,OR REFRACTORY SOLID TUMOR MALIGNANCIES No dispute reported 06/30/2026 1232935757
Principal investigator 1 BeOne Medicines USA, Inc. $14,580.00 09/23/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190332915
Principal investigator 1 BioNTech SE $289.85 09/18/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017096
Principal investigator 1 BeOne Medicines Ltd. $44,592.00 09/17/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190337193
Principal investigator 1 SANOFI US SERVICES INC. $243,944.53 09/05/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127833
Principal investigator 1 BeOne Medicines USA, Inc. $10,415.00 08/26/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190332923
Principal investigator 1 BioNTech SE $289.85 08/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017098
Principal investigator 1 SANOFI US SERVICES INC. $213,685.26 08/20/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127837
Principal investigator 1 Servier BioInnovation $1,009.06 08/08/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
S95029 Alone and in Combination with Sym021 in Patients with Advanced Solid Tumors followed by an Expansion Phase of Triple Combinations No dispute reported 06/30/2026 1235967289
Principal investigator 1 BioNTech SE $289.85 08/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017092
Principal investigator 1 BeOne Medicines USA, Inc. $20,498.00 07/22/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190332920
Principal investigator 1 SANOFI US SERVICES INC. $155,931.17 07/18/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127841
Principal investigator 1 SANOFI US SERVICES INC. $26,943.66 07/18/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127860
Principal investigator 1 SANOFI US SERVICES INC. $115,353.02 07/18/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127864
Principal investigator 1 BioNTech SE $289.85 07/17/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017094
Principal investigator 1 BioNTech SE $289.85 07/04/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017090
Principal investigator 1 BeOne Medicines Ltd. $55,740.00 07/02/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190342378
Principal investigator 1 PFIZER INC. $67,470.00 06/26/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
AN OPENLABEL PHASE 1 STUDY TO EVALUATE PF08046032 AS MONOTHERAPY AND PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED MALIGNANCIES No dispute reported 06/30/2026 1228851648
Principal investigator 1 BeOne Medicines Ltd. $43,712.00 06/18/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190342383
Principal investigator 1 BeOne Medicines Ltd. $25,613.00 06/17/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190330981
Principal investigator 1 BioNTech SE $289.85 05/22/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017080
Principal investigator 1 SANOFI US SERVICES INC. $210,725.94 05/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127714
Principal investigator 1 SANOFI US SERVICES INC. $90,926.36 05/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127730
Principal investigator 1 BeiGene, Ltd. $7,598.00 05/20/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190324566
Principal investigator 1 BeiGene, Ltd. $87,424.00 05/09/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190325340
Principal investigator 1 BioNTech SE $1,134.75 05/08/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017078
Principal investigator 1 Coherus Oncology, Inc. $4,661.35 04/25/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
SRF388-101 No dispute reported 06/30/2026 1235250649
Principal investigator 1 BeiGene, Ltd. $50,599.00 04/17/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190324564
Principal investigator 1 BeiGene, Ltd. $21,856.00 04/03/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190325346
Principal investigator 1 BeiGene, Ltd. $87,424.00 04/03/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190325348
Principal investigator 1 Karyopharm Therapeutics Inc. $4,270.00 04/02/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination with Multiple Standard Chemotherapy Agents in Patients with Advanced Malignancies No dispute reported 06/30/2026 1246662249
Principal investigator 1 BioNTech SE $7,356.75 04/01/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017072
Principal investigator 1 BeiGene, Ltd. $39,295.00 03/25/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190324560
Principal investigator 1 BioNTech SE $1,722.10 03/25/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017070
Principal investigator 1 SANOFI US SERVICES INC. $426,226.14 03/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127586
Principal investigator 1 BioNTech SE $4,882.40 03/19/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017066
Principal investigator 1 BioNTech SE $5,776.60 03/11/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017064
Principal investigator 1 SANOFI US SERVICES INC. $13,260.50 03/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127589
Principal investigator 1 SANOFI US SERVICES INC. $377,581.11 03/07/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127598
Principal investigator 1 BioNTech SE $128,229.51 03/06/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT151-01 No dispute reported 06/30/2026 1249017174
Principal investigator 1 BioNTech SE $23,432.80 02/25/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017062
Principal investigator 1 Karyopharm Therapeutics Inc. $2,400.00 02/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 2, Open-label Study of Selinexor (KPT-330) in Patients With Advanced Thymic Epithelial Tumor (TET) Progressing After Primary Chemotherapy (SELECT) No dispute reported 06/30/2026 1246662247
Principal investigator 1 BeiGene, Ltd. $27,784.00 02/18/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190324558
Principal investigator 1 BeiGene, Ltd. $98,352.00 02/12/2025 Non-covered Recipient Entity
UT MD Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190325354
Principal investigator 1 BioNTech SE $2,787.15 02/11/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017058
Principal investigator 1 BioNTech SE $2,331.55 02/05/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017056
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,750.00 01/23/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
CA099-003 - A Phase I/II Study of BMS-986408 Alone and In Combination with Nivolumab or with Nivolumab and Ipilimumab in Participants with Advanced Solid Tumors No dispute reported 06/30/2026 1235999545
Principal investigator 1 BeiGene, Ltd. $55,167.00 01/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Patients With Advanced Solid Tumors No dispute reported 06/30/2026 1190324562
Principal investigator 1 BioNTech SE $1,441.60 01/21/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017054
Principal investigator 1 BioNTech SE $4,828.85 01/17/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
BNT152-01C No dispute reported 06/30/2026 1249017050
Principal investigator 1 SANOFI US SERVICES INC. $5,624.90 01/10/2025 Covered Recipient Teaching Hospital
Ut Md Anderson Cancer Center
A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy in Adults With Advanced Solid Tumors No dispute reported 06/30/2026 1226127593